Newsroom | 29988 results

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the New England Journal of Medicine has published the full results of its TETON-1 study, as well as combined analyses of its TETON-1 and TETON-2 studies, evaluating the use of nebulized Tyvaso for the treatment of IPF. The publication is available here. A summary of the publication was also presented today during a symposium at th...

SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that the Company will participate in the following investor conference in June. On June 4, 2026, at 12:50 p.m. Eastern Time, Raj Asarpota, Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York City, NY. A live webcast of the fireside chat will be on th...

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle has named Katherine Palmer its Inventor of the Year, recognizing her exceptional contributions to translating cutting-edge materials science into real-world technologies that deliver meaningful societal impact. Palmer is widely recognized for solving complex “interface problems” that often determine whether a promising innovation succeeds outside the laboratory. Her work with carbon nanotube (CNT) materials has resulted in a robust intellectual property...

HAWTHORNE, Calif.--(BUSINESS WIRE)--Astrolab, an aerospace company building planetary rovers, today announced NASA payload customers for its first lunar mission aboard the company’s FLIP (FLEX Lunar Innovation Platform) rover. FLIP will fly aboard Astrobotic’s Griffin-1 lander, part of NASA’s Commercial Lunar Payload Services (CLPS) initiative. Griffin-1 will deliver payloads to the Moon’s south pole, advancing the Artemis campaign to return humans to the lunar surface. This mission is slated f...

PALO ALTO, Calif. & MCLEAN, Va.--(BUSINESS WIRE)--Atropos Health, the world’s largest creator of real-world evidence (RWE) for clinical decision making, and Guidehouse, a global professional services firm serving the commercial and government sectors, have launched a jointly developed clinical decision support (CDS) solution designed to operationalize RWE directly within clinical workflows. The CDS solution combines Atropos Health’s predictive modeling and evidence generation capabilities with...

LUGANO, Switzerland--(BUSINESS WIRE)--SERI Lugano Launches International Scientific Outreach Initiative on Light-Based Neuroscience and Pineal Gland Research...

MCLEAN, Va.--(BUSINESS WIRE)--NSTA announced the recipients of the Shell Urban Science Educators Development Award, who were recognized at its National Conference last month....

LA JOLLA, Calif.--(BUSINESS WIRE)--AeroRx Presents Positive Phase 2a Data for Inhaled AERO-007, the First Potential Nebulized LABA+LAMA Fixed-Dose Combination in Development for COPD...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the opening of a new bioanalytical and biomarker laboratory in Gothenburg, Sweden, located within GoCo Health Innovation City. This new facility expands the company’s global bioanalytical capabilities to support pharmaceutical and biotechnology customers across all phases of drug development. With state-of-the-art instrumentation and Good Laboratory Practice (GLP) capabilities, the la...

WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted, localized therapies for inflammatory skin diseases, today announced the appointment of Stephen M. Hahn, M.D., former Commissioner of the U.S. Food and Drug Administration (FDA), to oversee the clinical and regulatory strategy for GX-03, the Company’s investigational topical therapy currently in a Phase 2 clinical trial for moderate-to-severe atopic dermat...